GG&G

[Threepointer]

I just spoke to Andy and asked some basic questions. They are currently looking for a partner to roll out products in the U.S. He doesn't think a share buyback is an option. No timetable for a potential reverse split. Probably after sales increase. The Oxford study is ongoing. Because they didn't pay for it, Andy doesn't feel they can rush it. They are working on the bone and wound healing aspects using a more powerful device. He also said that FDA cleared the technology which opens the door for other uses. Baby steps for now.